Zimberelimab plus lenvatinib showed immune rechallenge effects in 30 patients with advanced cervical cancer
Small trial finds immune rechallenge may help some advanced cervical cancer patients
This multicenter, single-arm, phase II trial evaluated combined zimberelimab and lenvatinib in 30 patients with advanced cervical cancer who…
A small study of 30 patients suggests combining zimberelimab and lenvatinib after prior treatment might help some with advanced cervical can…
Combination therapy shows promising progression-free survival in advanced non-small cell lung cancer patients with high PD-L1 expression
Early trial shows two-drug combo may help advanced lung cancer patients
This randomized phase 2 trial evaluated domvanalimab plus zimberelimab compared to zimberelimab alone or chemotherapy in patients with advan…
A Phase 2 trial suggests a two-drug combination might improve outcomes for some patients with advanced lung cancer compared to standard chem…